rs753307105

Variant summary

Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate

The NM_138694.4(PKHD1):​c.4292G>T​(p.Cys1431Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C1431S) has been classified as Pathogenic.

Frequency

Genomes: not found (cov: 32)

Consequence

PKHD1
NM_138694.4 missense

Scores

9
6
4

Clinical Significance

Likely pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 2.68
Variant links:
Genes affected
PKHD1 (HGNC:9016): (PKHD1 ciliary IPT domain containing fibrocystin/polyductin) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 12 ACMG points.

PM1
In a domain IPT/TIG 9 (size 92) in uniprot entity PKHD1_HUMAN there are 9 pathogenic changes around while only 0 benign (100%) in NM_138694.4
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr6-52025519-A-T is described in Lovd as [Pathogenic].
PP3
MetaRNN computational evidence supports a deleterious effect, 0.991
PP5
Variant 6-52025518-C-A is Pathogenic according to our data. Variant chr6-52025518-C-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 1466642.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PKHD1NM_138694.4 linkuse as main transcriptc.4292G>T p.Cys1431Phe missense_variant 32/67 ENST00000371117.8 NP_619639.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PKHD1ENST00000371117.8 linkuse as main transcriptc.4292G>T p.Cys1431Phe missense_variant 32/671 NM_138694.4 ENSP00000360158 P2P08F94-1
PKHD1ENST00000340994.4 linkuse as main transcriptc.4292G>T p.Cys1431Phe missense_variant 32/615 ENSP00000341097 A2P08F94-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
35
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Autosomal recessive polycystic kidney disease Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpAug 19, 2021This sequence change replaces cysteine with phenylalanine at codon 1431 of the PKHD1 protein (p.Cys1431Phe). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and phenylalanine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with PKHD1-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PKHD1 protein function. This variant disrupts the p.Cys1431 amino acid residue in PKHD1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 27225849; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.79
BayesDel_addAF
Pathogenic
0.34
D
BayesDel_noAF
Pathogenic
0.25
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.90
D;.
Eigen
Uncertain
0.27
Eigen_PC
Benign
0.15
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.73
T;T
M_CAP
Pathogenic
0.31
D
MetaRNN
Pathogenic
0.99
D;D
MetaSVM
Uncertain
0.22
D
MutationAssessor
Pathogenic
3.0
M;M
MutationTaster
Benign
0.81
N;N
PrimateAI
Benign
0.38
T
PROVEAN
Pathogenic
-9.2
D;D
REVEL
Pathogenic
0.83
Sift
Uncertain
0.0040
D;D
Sift4G
Uncertain
0.0070
D;D
Polyphen
1.0
D;P
Vest4
0.84
MutPred
0.90
Gain of sheet (P = 0.0149);Gain of sheet (P = 0.0149);
MVP
0.98
MPC
0.45
ClinPred
1.0
D
GERP RS
5.0
Varity_R
0.96
gMVP
0.95

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr6-51890316; API